eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2006
vol. 23
 
Share:
Share:
abstract:

REVIEW PAPER
Cardiovascular mortality in rheumatoid arthritis patients

Jacek Olas
,
Grzegorz Gajos
,
Jolanta Bucka
,
Alicja Włoch
,
Agata Dworak
,
Renata Kolasa
,
Włodzimierz Samborski

Post Dermatol Alergol 2006; XXIII, 1: 26–30
Online publish date: 2006/02/24
View full text Get citation
 
Rheumatoid Arthritis (RA) is a chronic inflammatory disease of joints that affects also cardiovascular system. As a consequence of it, coronary artery disease (CAD) and heart failure (HF) with cardiac deaths, appear more than double comparing to the general population. Vascular endothelial dysfunction with accelerated atherosclerotic process, imbalance in the autonomic nervous system, and delay in the process of diagnosis and management are found among reasons leading to increased mortality of RA patients. It was observed that RA patients may develop CAD and HF even on early stages of the disease, regardless of lack of traditional cardiovascular risk factors and with absence of angina symptoms. Accordingly, there is a need for reliable and simple screening test addressed for asymptomatic patients from group of high risk of cardiovascular disease. Identifying high risk patients with Systemic Coronary Risk Evaluation (SCORE), basic additional findings and assessment of cardiac markers (CRP, BNP), should be done in every case of clinical evaluation of RA patient.
keywords:

rheumatoid arthritis (RA), coronary artery disease (CAD), congestive heart failure (HF)

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.